Tongji Hospital is a 300 patient bed hospital. Founded in 1993, with a well-echeloned staff structure, it offers a full range of gynecology services at a convenient geographic location. The acquisition of Xiamen Tongji Hospital accelerates BioPharm Asia’s strategy, which aims to increase the accessibility of patient care for big cities with underserved, growing affluent middle class in China.

“BioPharm Asia continues to invest in the key emerging markets such as Xiamen where the combination of growing populations and increasing income are driving demand and expectations for better healthcare treatment,” said Xiayang Hu, president of BioPharm Asia, Inc. “Our new acquisition further underscores our intention to serve the health needs of Xiamen patients through our specialized services and, increasingly, high-quality branded generic treatments that are locally produced to global standards.”

“As China’s economy has continuously made stride in recent history, a rising middle class with greater spending power demands higher quality of healthcare, but the truth is that they don’t have many alternatives to choose. The company’s new marketing plans should be able to make inroads with increasingly health-conscious urban customers.”

About BioPharm Asia, Inc.

BioPharm Asia, Inc. is engaged in the retail sale of medical products in China, complemented by vertically integrated supporting functions that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. For more information, please visithttp://www.biopharmasiainc.com.

Mitchell Adam, President states, “BonTerra is pleased to have such an experienced and reputable company conduct our gold resource calculation.”

About Geopoint

Geopoint is a mining services company which focuses on providing specialized geostatistic services and National Instrument 43-101 compliant resource estimation. Gepoint is based in Val d’Or, Quebec and has been in business since March of 2000. Geopoint’s client list includes Agnico Eagle Mines, Bema Gold, Aurizon Mines, Wesdome Mines, Virginia Mines and Richmont Mines.

About BonTerra Resources

BonTerra is a Canadian gold exploration company focused on continuing to expand the drill defined gold zones on the Property, part of the world famous Abitibi Greenstone Belt in mining friendly Quebec. BonTerra has a total of three gold properties in the Urban-Barry belt, the Eastern Extension, Lavoie and Urban-Barry properties which are located approximately 170 km NE of Val-d’Or and 125 km SW of Chibougamau in the Urban, Barry and Bailly townships in Quebec.

BonTerra has an option to earn 100% of the Eastern Extension property from Abitex Resources subject to a 2% NSR.

Qualified Person

The technical content of this press release has been reviewed and accepted by Thomas Clarke, Pr.Sci.Nat., a Director of BonTerra. Mr. Clarke is a Qualified Person under NI 43-101.

ON BEHALF OF THE BOARD

BONTERRA RESOURCES INC.

Mitchell Adam, President, Director

This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as the statement that the Company: (i) currently awaits the final assay data to be used for the NI 43-101 compliant resource calculation for the Property; and (ii) is focused on continuing to expand the drill defined gold zones on its Eastern Extension property. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) delays with respect to drill results or preparation of a resource calculation; (iii) inability to prepare a resource calculation on the Property for any reason; and (iv) general uncertainties with respect to mineral exploration in general. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

GRDH CEO, Steve Cochennet, cited the availability of highly talented management and the strength of the investor market as key reasons for the move. “We began our search for key skills as well as supporting suppliers, and Scottsdale has its own center of gravity that serves the company rather well.”

Scottsdale Mayor, Jim Lane, added, “We are very pleased to welcome Guardian 8 to the growing number of thought leading companies choosing Scottsdale. The people coming to Scottsdale with Guardian 8 are creative innovators who chose our city because of the talented people and positive business environment here. It is a great fit, and I am sure they will be another very successful Scottsdale company.” Cochennet concluded by saying, “Our expectation is that the pool of investors in Arizona and the southwest will be paying particular attention to our work.”

The G8 device, designed and to be sold by Guardian 8, is an award winning multi-functional pepper spray based platform which is enabled with Bluetooth® connectivity features, a camera and a microphone which help enhance incident reporting.

About Guardian 8 Holdings

Guardian 8 Holdings, through its wholly owned operating subsidiary Guardian 8 Corporation, is the developer and manufacturer of the G8 Personal Defense Device, a unique and innovative product which combines eight non-lethal technologies designed to prevent and protect an individual from aggressors and assailants, while notifying law enforcement or others of the situation. The small, easy to use hand-held unit integrates an alerting siren, LED strobe light, laser spotter, camera, microphone, emergency notification, and pepper spray. The company plans to market their personal defense solution to professional security organizations, as well as individuals and families. To learn more about the company and its device, visit www.Guardian8.com.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.”

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the addition of Ms. Hanrahan, Mr. Lambrecht and Mr. Nolton as board members; benefits of the move to Scottsdale, Arizona; Guardian 8′s and its subsidiaries business prospects; the ability of Guardian 8 to execute its business plan; benefits of the G8 device; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Important factors that could cause actual results to differ materially from the forward-looking statements Guardian 8 makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. Guardian 8 undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

The Las Vegas Market is among the largest home décor shows in the world drawing attendees from around the World. There is over 5 million square feet of exhibition space with buyers from all of the top retailers.

Get Down Art will be showcasing world famous artist Stephen Fishwick’s “For Life” and “Icons” Collections in open edition canvas and paper prints. Both collections are building in sales every month, and the Las Vegas Market will give the company an opportunity to increase sales and distribution.

Brandon Donofrio, President of Dig-It Underground Inc. stated, “We are excited to exhibit at the Las Vegas Market and believe that is a great fit for our products. The show will give ability to show our products to thousands of buyers and open up new accounts.”

Get Down Art is a 6-year-old Las Vegas based company specializing in the Worldwide marketing of consumer products to retailers, specializing in apparel, branding intellectual properties, and graphic illustrations of world famous artists and brands including Sin City Kitty™. The company’s e-commerce website can be viewed at www.getdownart.com.

The information contained in this release consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward–looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, and competition in general that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward – looking statements whether as a result of new information, future events or otherwise.

Get Down Art’s first order for Event Network Inc. has been shipped to the Georgia Aquarium Store, due to arrive the first week of January 2012. Stephen Fishwick’s “For Life” Collection of artwork will be featured at the Georgia Aquarium Store. The Stephen Fishwick “For Life” Collection is a series of artwork based on endangered species that hopes to raise awareness and funds to assist in saving the many habitats and animals that are being threatened.

Brandon Donofrio, President of Dig-It Underground Inc., stated, “Event Network, Inc. is a very impressive company with a passion for retail. We are honored to be a new vendor with them. We are looking forward to a long-term relationship that will increase the exposure for the Stephen Fishwick art collections and make unique products with Event Network, Inc. We will be updating new exciting additions to our relationship over the next several months.”

Get Down Art is a 6-year-old Las Vegas based company specializing in the worldwide marketing of consumer products to retailers, specializing in apparel, branding intellectual properties, and graphic illustrations of world famous artists and brands including Sin City Kitty™. The company’s e-commerce website can be viewed at www.getdownart.com.

The information contained in this release consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward–looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, and competition in general that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward–looking statements whether as a result of new information, future events or otherwise.

Get Down Art has had seven titles in the over 600 Spencer’s Gifts Stores during the 2011 holiday season, and the new Stephen Fishwick ‘Watch Tower” title continues our established relationship.

The Stephen Fishwick “Watch Tower” was commission by the Hard Rock Hotels. The massive 5-foot by 7-foot original hangs in the Hard Rock Hotel in Sydney, Australia. The Stephen Fishwick “Icons” Collection is a series of original paintings that are artist interpretations of iconic people, places and things.

Brandon Donofrio, President of Dig-It Underground Inc., stated, “Spencer’s Gifts has over 600 stores across the United States and continues to be a great account for us. We look to expand our relationship with Spencer’s in 2012 with additional products and categories.”

Get Down Art is a six-year-old Las Vegas-based company specializing in the worldwide marketing of consumer products to retailers, specializing in apparel, branding intellectual properties, and graphic illustrations of world-famous artists and brands, including Sin City Kitty™. The company’s e-commerce website can be viewed at www.getdownart.com.

The information contained in this release consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward–looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, and competition in general that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward – looking statements whether as a result of new information, future events or otherwise.

The 5-year Distribution Agreement calls for a minimum purchase of $13 million USD and gives Premium Pharma the exclusive right to market and sell Sucanon® through its established distribution channels and will begin shortly the regulatory process with the Ministries of Health for the sale of Sucanon^®. Fero is also taking the necessary steps to comply with the United States government for this Agreement, and the companies expect to complete the licencing process and commence shipping of Sucanon^® within a year.

“We are thrilled to be able to expand our presence within the Greater Middle East region to distribute Sucanon^® with a well-established and reputable partner,” said Mr. Luis Lopez , President and COO of Fero Industries.  “Premium Pharma’s regional business and consumer knowledge, along with their established pharmaceutical and healthcare products distribution network, makes them an ideal partner to expand this business model across the Middle East . This new agreement represents a major financial milestone for Fero, as it brings the total in minimum product to be purchased to $24 million USD for the region. We are working to expedite the necessary approvals from the various US government agencies and expect notification soon. This agreement validates Sucanon as a major new drug for Type II diabetes.”

Iran and other countries in the Middle East have one of the largest and fastest growing diabetic populations in the world.  Six countries in the Middle East and North African Region rank among the world’s top ten for diabetes prevalence.  According to the World Health Organization, current estimates show that 26.6 million people have Type-II diabetes in the region (7.7% of the adult population) with that number expected to nearly double in the next 20 years.  Similarly, the number of people with Impaired Glucose Intolerance (“IGT”) or “pre-diabetes” is estimated to be an additional 24.4 million cases (7.1% of the adult population).  Healthcare costs associated with diabetes in the region were estimated to be $5.6 billion in 2010.

“The rapidly increasing number of people with Type-II diabetes in the Middle East is a direct indicator of the need for Sucanon® in the region. We are proud to have aligned ourselves with a company of Premium Pharma’s caliber to mark our entry into this important geographical sector,” stated Mr. Lopez.

About Sucanon^®

Sucanon^® is one of only three approved drugs in the multi-billion dollar market for a class of diabetic medications called “insulin sensitizers.”  Pre-clinical and clinical studies show that Sucanon^®and other insulin sensitizers lower a patient’s blood sugar by increasing the muscle, fat and liver’s sensitivity to the body’s own naturally produced insulin.  Sucanon^® has been approved for prescription sale in China , Peru and Mexico.  Sucanon^® is also approved as an OTC treatment for Type-II diabetes by regulatory authorities in Mexico , and is distributed there under an exclusive agreement with Merck S.A. de C.V.

For further information regarding Sucanon^®, please visit the Fero Industries, Inc. website atwww.feroindustries.com.

About Fero Industries, Inc.

Fero Industries, Inc. (OTCQB: FROI.PK - News) is focused on diabetes prevention and treatments.  The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon^®, an oral treatment for Type-II diabetes.  Sucanon^® is a member of a class of diabetic medications called insulin sensitizers.  Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver’s sensitivity to insulin.  Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.  Fero’s strategy is to increase awareness, acceptance, and distribution of Sucanon^® globally.

For investor relations contact:

Michael Irving
Paramount Advisors, LLC
(407) 878-5462

Certain statements in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements may be identified by the use of words such as “anticipate,” “believe,” “expect,” “future,” “may,” “will,” “would,” “should,” “plan,” “projected,” “intend,” and similar expressions.  Such forward-looking statements, involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Fero Industries, Inc. (the Company) to be materially different from those expressed or implied by such forward-looking statements.

The Company’s future operating results are dependent upon many factors, including but not limited to the Company’s ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company’s control; and (iv) other risk factors discussed in the Company’s periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov under “Search for Company Filings.”

For additional information on Fero Industries, Inc. (OTCQB: FROI) visit http://www.stockorange.com/client-profiles/froi

For hot penny stocks, daily small cap alerts, and stock market news alerts visit http://www.stockorange.com

Alexander Salazar Fine Art is proud to announce a fun-filled art exposition featuring world famous artist Stephen Fishwick and his “Icons” Collection featuring Elvis Presley, the King of Rock ‘n’ Roll. Fishwick will marvel the crowd with his “Paint in Motion” show where he paints giant original portraits in less than seven minutes on stage. During the fun-filled evening of festivities, Fishwick will paint GIANT original Elvis paintings as the crowd rocks with him. Along with the performance, Fishwick will be available to meet collectors, take photographs, and dedicate any Fishwick artwork purchases. To see Fishwick’s “Paint in Motion” video performance, visit: http://www.getdownart.com/stephen_fishwick_videos.html.

The Fishwick art brand continues to astonish the world. His business experience includes nearly two decades of producing artwork for corporate America, with professional clients that include The National Football League, Microsoft, Apple, Coca-Cola, Volkswagen, Honda, Anheuser-Busch, Disney, Busch Gardens Florida, San Diego Padres and National Geographic to name a few. Fishwick’s worldwide schedule has millions of eyes on his artwork annually.

At the exposition, Fishwick will unveil new original Elvis Presley artwork and a collection of limited-edition artwork priced from $150 and up. Artwork is limited and is available on a first-come, first-served basis. Contact the gallery for your chance to win a VIP Vegas trip valued at $2,000 that will be given away at the show, package provided by vegasVIPinsiders.com, a San Diego-based company that offers clients a full-suite of Las Vegas VIP services at discounted prices. To Reserve your artwork and RSVP for this historic event contact Alexander Fine Art, 1040 7^th Avenue San Diego, CA, 619- 531-8996.

Get Down Art is a 6 year old Las Vegas based company specializing in the World Wide marketing of consumer products to retailers, specializing in apparel, branding intellectual properties, and graphic illustrations of world famous artists and brands including Sin City Kitty™. The company’s website can be viewed at www.getdownart.com.

The information contained in this release consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward–looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, and competition in general that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward–looking statements whether as a result of new information, future events or otherwise.

For additional information on Dig-It Underground, Inc. (OTC: DIGX) visit http://www.stockorange.com/client-profiles/digx

For hot penny stocks, daily small cap alerts, and stock market news alerts visit http://www.stockorange.com

NEW YORK, NY and TONGHUA, CHINA–(Marketwire -12/19/11)- BioPharm Asia (Pinksheets: BFAR.PK - News) and Elite Capital Group announced today the signing of a consulting agreement for the development of a 1,000-bed Fangzhuang Hospital and Training Center to be located in Fangzhuang, Beijing. BioPharm Asia will serve as master consultant for the project which is scheduled to begin construction in 2012.

Xiayang Hu, CEO of BioPharm Asia, said, “We are delighted to confirm Elite Capital Group’s contract in which our Hospital Management Division will provide key development services as well as assist in the operations of the facility. We are confident that we have the range of skills and services to help Elite Capital Management create new models of healthcare and flexible therapeutic environments.”

Andrew Lee, Partner & Managing Director of Elite Capital Group, said, “Substandard healthcare is changing in China, especially the rapid economic progress has improved the financial well being of china’s growing middle class. The demands of courteous healthcare professionals in the residential area have risen sharply. Our focus is to pursue this major phenomenon in the Chinese healthcare marketplace and with the help of BioPharm Asia’s hospital management expertise to develop a chain of efficient, clean, well-maintained hospitals.”

About BioPharm Asia, Inc.

BioPharm Asia, Inc. is engaged in the retail sale of medical products in China, complemented by vertically integrated supporting functions that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. For more information, please visithttp://www.biopharmasiainc.com.

For additional information on BioPharm Asia, Inc. (OTC: BFAR) visit http://www.stockorange.com/client-profiles/bfar

For hot penny stocks, daily small cap alerts, and stock market news alerts visit http://www.stockorange.com

Joining GRDH are Kathy Hanrahan, former President of TASER® International; Corey Lambrecht, Former EVP of Smith & Wesson Holding Corporation; and Jim Nolton, Strategic Business Development Manager and Sr. Systems Engineer for Orbital Sciences Corp.

“We set our sights upon leaders with a proven track record to make a difference in fine tuning our strategic plan, perfecting our product, and getting us to market. Thankfully, all three of these highly successful individuals saw the same opportunity we did with Guardian 8. Our team is pleased to have them, and given their respective talents and backgrounds, I believe it’s fair to say that the company is in a strong position for 2012 and beyond with these team improvements,” said Steve Cochennet, CEO of GRDH.

Most noted for aiding TASER® International in its growth from under $2M to over $100M in revenue per year, Kathy Hanrahan brings a strong background of performance in dealing with complex business strategy, operation’s management and accounting. Her expertise is expected to assist Guardian 8 and the G8 Personal Defense Device to achieve lasting financial success. Prior to being appointed the President of TASER® in 2006, Ms. Hanrahan served as CFO through TASER’s® Initial Public Offering in 2001, and as the Company’s Chief Operations Officer from 2004 through 2006. Currently she serves on the Advisory Board for EmpowHER, a Scottsdale based digital media company, as well as Corporate director for Meridian Bank, N.A., where she serves on the Board’s Audit, Compensation, and Compliance Committee. She also serves several charitable organizations throughout Arizona, including her position as Board Member for the YWCA of Maricopa County.

Corey Lambrecht is known for his achievements in three highly regulated industries — alcohol, tobacco, and firearms. His experience within the capital markets as a senior pre-public and public company executive, combined with his innate ability to capture top tier accounts bolsters Guardian 8′s growing roster of talent. He is known for spearheading the acquisition of Smith & Wesson Holding Corporation and re-directing the business model back toward its “roots” in development, as well as his role as VP of Sales and Marketing for Premium Cigars International — a NASDAQ company.

Jim Nolton carries a Mechanical Engineering degree accompanied by a Master’s Degree in Global Business Strategies, where he ranked 4th in his graduating class. His current consulting role at Orbital Sciences Corporation includes leading multi-discipline engineering teams through the entire conceptual phase, new business development process, and contract negotiations. Orbital designs and manufactures rockets and satellites for commercial applications and the US Government. Jim was co-founder of the NASDAQ traded IGo Corp. where he was the New Product Development Sr. Systems Engineer, Sr. Program Manager, & Director of Systems Test/Verification/Integration. He led new product development and manufacturing teams in the mobile computing industry. He spent time with General Dynamics where he assisted in the Tomahawk Cruise Missile engineering, as well as other classified missile and rocket launch systems. His broad engineering knowledge of the high-tech consumer electronics and military defense industry rounds out the latest additions to Guardian 8 Holdings’ board of directors.

About Guardian 8 Holdings

Guardian 8 Holdings, through its wholly owned operating subsidiary, Guardian 8 Corporation, is the developer and manufacturer of the G8 Personal Defense Device, a unique and innovative product which combines eight non-lethal technologies designed to prevent and protect an individual from aggressors and assailants, while notifying law enforcement or others of the situation. The small, easy to use hand-held unit integrates an alerting siren, LED strobe light, laser spotter, camera, microphone, emergency notification, and pepper spray. The company plans to market their personal defense solution to professional security organizations, as well as individuals and families. To learn more about the company and its device, visit www.Guardian8.com.

Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.”

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the addition of Ms. Hanrahan, Mr. Lambrecht and Mr. Nolton as board members; each members prior experience and expertise; Guardian 8′s and its subsidiaries business prospects; the ability of Guardian 8 to execute its business plan; benefits of the G8 device; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Important factors that could cause actual results to differ materially from the forward-looking statements Guardian 8 makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. Guardian 8 undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.